Human biospecimen procurement may be easier than you think – an article by BIOMEDICA CRO team.
Biospecimen procurement might not be an easy task for procurement managers when they act as an intermediary between scientists and a biospecimen collection company. This scheme may be even more complicated and unclear when collection is done by a broker.
Just imagine what are the chances to satisfy initial scientist request when information and communication flow looks like this:
- Scientist tells the procurement manager the research needs;
- Procurement manager sends a request to the bio broker or to the marketplace;
- Bio broker usually doesn’t have own collection capacities so have to contact specialized biospecimen company which is going to be responsible for human samples collection;
- Specialized biospecimen company approaches the primary investigators (physicians who will personally contact patients and collect necessary biospecimens).
As you see, the path from initial scientist’s need and final execution is pretty long. Very often scientists can not formulate requests with appropriate levels of necessary details which may cause questions during the collection process. In this case the communication stream goes backwards from physician to scientist through a number of managers who might not have scientific education but just business one. This causes difficulties, disruptions and delays in communication.
Needless to say, during the project some requirements may be changed or modified which again require additional communication with the final executor.
Now imagine that you are in a hurry and project timelines are the first priority. What results will you have then? In such circumstances this question sounds rather rhetorical.
Even when you have enough time (which is rather exceptional) the probability that all project details and conditions will be followed appropriately is critically low.
The easiest way to solve this issue is to shorten the distance between project owner and final executor.
The best option for that might be BIOMEDICA CRO, as a company which only has its own human biospecimen collection but no brokerage of other companies’ samples. By collecting specimens by ourselves, we ensure an easy, fast and faultless communication with the executors. BIOMEDICA CRO team is in constant contact with clinical sites as well as primary investigators (physicians) and always ready to provide you with the latest collection feedback. Direct contact to physicians ensures their proper understanding of collections details and high quality of collected biospecimens.
Please email us to start our collaboration: office@biomedica-cro.com / LinkedIn or visit our page to find out more about us.
